Deal Library / Pharma BD Deal Intelligence

Teva Pharmaceutical Industries Ltd. — Pharma Deals

The Pharma Closeout tracks 17 deals, $161.4B in disclosed deal value, 14 with a post-close Outcome Score for Teva Pharmaceutical Industries Ltd..

Median Critic Score: 73  ·  Median Outcome Score: 54

Best outcome: Teva Pharmaceutical Industries Ltd. / Auspex Pharmaceuticals (86)  ·  Weakest outcome: Teva Pharmaceutical Industries Ltd. / Rimsa (8)

All 17 deals

• Teva Pharmaceutical Industries Ltd. / Auspex Pharmaceuticals — 2015 · $3.5B · Worked — the deal delivered on its rationale.
• Teva Pharmaceutical Industries Ltd. / Biogal Pharmaceutical — 1995 · Worked — the deal delivered on its rationale.
• Teva Pharmaceutical Industries Ltd. / Sicor Inc. — 2003 · $3.4B · Largely worked — most objectives met.
• Teva Pharmaceutical Industries Ltd. / IVAX Corporation — 2006 · $7.4B · Largely worked — most objectives met.
• Teva Pharmaceutical Industries Ltd. / Ivax Corporation — 2005 · $7.4B · Largely worked — most objectives met.
• Teva Pharmaceutical Industries Ltd. / Novopharm Limited — 2000 · $600M · Largely worked — most objectives met.
• Teva Pharmaceutical Industries Ltd. / Barr Pharmaceuticals — 2008 · $7.5B · Mixed — partial payoff, real shortfalls.
• Teva Pharmaceutical Industries Ltd. / Samsung Bioepis Co., Ltd. — 2026 · Mixed — partial payoff, real shortfalls.
• Teva Pharmaceutical Industries Ltd. / Cephalon Inc. — 2011 · $6.8B · Mixed — partial payoff, real shortfalls.
• Teva Pharmaceutical Industries Ltd. / Honeywell Pharmaceutical Fine Chemicals S.r.l — 2002 · Underwhelmed — fell short of the thesis.
• Teva Pharmaceutical Industries Ltd. / Allergan plc (Actavis Generics business) — 2016 · $40.5B · Did not work — the deal failed to deliver.
• Teva Pharmaceutical Industries Ltd. / Allergan plc (Generics Business) — 2015 · $40.5B · Did not work — the deal failed to deliver.
• Teva Pharmaceutical Industries Ltd. / Allergan plc (Anda Inc.) — 2016 · $500M · Did not work — the deal failed to deliver.
• Teva Pharmaceutical Industries Ltd. / Rimsa — 2015 · $2.3B · Did not work — the deal failed to deliver.
• Teva Pharmaceutical Industries Ltd. / Emalex Biosciences, Inc. — 2026 · $900M
• Teva Pharmaceutical Industries Ltd. / Mylan N.V. — 2015 · $40.0B
• Teva Pharmaceutical Industries Ltd. / Bayer Classics (Bayer Pharma S.A. French generics division) — 2002 · $86M

← Deal Library  ·  Interactive search  ·  How we score deals